Saloni Chopra
Doktorand vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerprecisionsmedicin; Forskargrupp Marika Nestor
- E-post:
- saloni.chopra@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
Publikationer
Senaste publikationer
-
[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
Ingår i EJNMMI Research, 2026
- DOI för [161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
- Ladda ner fulltext (pdf) av [161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
-
Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
Ingår i Endocrine, s. 626-637, 2024
- DOI för Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
- Ladda ner fulltext (pdf) av Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
-
Ingår i Cancers, 2023
- DOI för Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
- Ladda ner fulltext (pdf) av Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
Alla publikationer
Artiklar i tidskrift
-
[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
Ingår i EJNMMI Research, 2026
- DOI för [161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
- Ladda ner fulltext (pdf) av [161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
-
Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
Ingår i Endocrine, s. 626-637, 2024
- DOI för Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
- Ladda ner fulltext (pdf) av Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
-
Ingår i Cancers, 2023
- DOI för Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
- Ladda ner fulltext (pdf) av Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts